TAK-085: Clinical Trials

2 trials of TAK-085, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow TAK-085: new trials by email Literature Review of TAK-085 trials Research Report on TAK-085

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of TAK-085 in Participants With Hypertriglyceridemia
Omega-3-acid ethyl esters 90 (TAK-085), Eicosapentaenoic acid-ethyl (EPA-E) - Hypertriglyceridemia
Phase 3CompletedTakeda6112009-11-012016-09-20
Long-term Efficacy and Safety Study of TAK-085 in Participants With Hypertriglyceridemia
omega-3-acid ethyl esters 90 (TAK-085), Eicosapentaenoic acid-ethyl (EPA) - Hypertriglyceridemia
Phase 3CompletedTakeda5032009-11-012016-09-20

Conditions studied

Hypertriglyceridemia (2)

Sponsors

Takeda (2)

Top investigators

Associate Professor, Clinical Cell Biology and Medicine (2)